Hepatitis C and human immunodeficiency virus infection

被引:121
作者
Thomas, DL [1 ]
机构
[1] Johns Hopkins Sch Med, Div Infect Dis, Viral Hepatitis Sect, Baltimore, MD USA
关键词
D O I
10.1053/jhep.2002.36380
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In the United States, an estimated 200,000 persons are infected with both hepatitis C virus (HCV) and human immunodeficiency virus (HIV). As the lives of HIV-infected persons have been prolonged by use of highly active antiretroviral therapy, liver disease has emerged as an important, and in some settings, the leading cause of morbidity and mortality. Human immunodeficiency virus infection appears to adversely affect all stages of hepatitis C infection, leading to increased viral persistence and accelerated progression of HCV-related liver disease. In turn, hepatitis C may affect the management of HIV infection, increasing the incidence of liver toxicity caused by antiretroviral medications. The medical management of hepatitis C in HIV-infected persons remains controversial, in part because of the complexity of both infections and potential drug interactions, but chiefly because there is so little published information. Nonetheless, the burden of liver disease is too high to delay management of HIV/HCV-coinfected persons while awaiting better data. instead, the management of hepatitis C today must be based on data generated on persons without HIV and an understanding of both infections. Properly designed studies of therapy in HIV/HCV-coinfected persons are needed to help guide management of these patients in the future.
引用
收藏
页码:S201 / S209
页数:9
相关论文
共 95 条
[11]   TRANSFUSION-ASSOCIATED HEPATITIS AND AIDS - WHAT IS THE RISK [J].
BOVE, JR .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (04) :242-245
[12]   RECOMBINANT INTERFERON-ALPHA FOR CHRONIC HEPATITIS-C IN PATIENTS POSITIVE FOR ANTIBODY TO HUMAN-IMMUNODEFICIENCY-VIRUS [J].
BOYER, N ;
MARCELLIN, P ;
DEGOTT, C ;
DEGOS, F ;
SAIMOT, AG ;
ERLINGER, S ;
BENHAMOU, JP .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (04) :723-726
[13]  
Brunetto MR, 1998, LANCET, V351, P1535
[14]   HEPATITIS-C VIRUS-INFECTION IN SEXUALLY ACTIVE HOMOSEXUAL MEN [J].
BUCHBINDER, SP ;
KATZ, MH ;
HESSOL, NA ;
LIU, J ;
OMALLEY, PM ;
ALTER, MJ .
JOURNAL OF INFECTION, 1994, 29 (03) :263-269
[15]   QUIESCENT LYMPHOCYTES-T AS AN INDUCIBLE VIRUS RESERVOIR IN HIV-1 INFECTION [J].
BUKRINSKY, MI ;
STANWICK, TL ;
DEMPSEY, MP ;
STEVENSON, M .
SCIENCE, 1991, 254 (5030) :423-427
[16]   Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French departments of internal medicine/infectious diseases, in 1995 and 1997 [J].
Cacoub, P ;
Geffray, L ;
Rosenthal, E ;
Perronne, C ;
Veyssier, P ;
Raguin, G .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (08) :1207-1214
[17]  
CDC, 2001, Morbidity and Mortality Weekly Report, V50, P1
[18]   LOSS OF ANTIBODIES AGAINST HEPATITIS-C VIRUS IN HIV-SEROPOSITIVE INTRAVENOUS-DRUG-USERS [J].
CHAMOT, E ;
HIRSCHEL, B ;
WINTSCH, J ;
ROBERT, CF ;
GABRIEL, V ;
DEGLON, JJ ;
YERLY, S ;
PERRIN, L .
AIDS, 1990, 4 (12) :1275-1277
[19]   Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection [J].
Chun, TW ;
Carruth, L ;
Finzi, D ;
Shen, XF ;
DiGiuseppe, JA ;
Taylor, H ;
Hermankova, M ;
Chadwick, K ;
Margolick, J ;
Quinn, TC ;
Kuo, YH ;
Brookmeyer, R ;
Zeiger, MA ;
BarditchCrovo, P ;
Siliciano, RF .
NATURE, 1997, 387 (6629) :183-188
[20]   HIGH HEPATITIS-C VIREMIA AND IMPAIRED ANTIBODY-RESPONSE IN PATIENTS COINFECTED WITH HIV [J].
CRIBIER, B ;
REY, D ;
SCHMITT, C ;
LANG, JM ;
KIRN, A ;
STOLLKELLER, F .
AIDS, 1995, 9 (10) :1131-1136